Table 2.
Common drug targets and similarities.
| Target | SLE | RA | pSS | SSc | LVV | AAV | IIM |
|---|---|---|---|---|---|---|---|
| Type I IFN/IFNR | ✓ | ✓ | ✓ | ||||
| IL-17/IL-17R | ✓ | ✓ | |||||
| GM-CSFR | ✓ | ✓ | |||||
| BAFF/BAFF receptor | ✓ | ✓ | ✓ | ||||
| CD40/40L | ✓ | ✓ | ✓ | ||||
| JAK/STAT | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| IL-6/IL-6R | ✓ | ✓ | |||||
| CD20 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| CD19 | ✓ | ✓ | ✓ | ||||
| CD38 | ✓ | ✓ |
AAV, ANCA-associated vasculitis; GM-CSFR, GM-CSF receptor; IFNR, interferon receptor; IL-6R, IL-6 receptor; IL17R, IL-17 receptor; IIM, idiopathic inflammatory myopathy; LVV, large-vessel vasculitis; pSS, primary Sjögren’s syndrome; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SSc, systemic sclerosis.